论文信息 - TOPARP-B: A phase II randomized trial of the poly(ADP)-ribose polymerase (PARP) inhibitor olaparib for metastatic castration resistant prostate cancers (mCRPC) with DNA damage repair (DDR) alterations. - 字舞流文

TOPARP-B: A phase II randomized trial of the poly(ADP)-ribose polymerase (PARP) inhibitor olaparib for metastatic castration resistant prostate cancers (mCRPC) with DNA damage repair (DDR) alterations.

J. Bono | A. Espinasse | E. Hall | Robert J. Jones | S. Crabb | T. Elliott | M. Varughese | S. Miranda | J. Mateo | S. Carreira | I. Syndikus | C. Ralph | D. Bianchini | N. Porta | O. Parikh | C. Bertan | G. Seed | U. McGovern | S. Jain | P. Chatfield